Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ZWZH-21

😃Good
Catalog No. T212544Cas No. 3069195-42-9

WZH-21 is a selective and orally active dual HDAC1/2 inhibitor, exhibiting an IC50 of 34 nM for HDAC1 and 41 nM for HDAC2. It inhibits the growth of HCT116 and SW480 cells with IC50 values of 0.524 μM and 1.063 μM, respectively. WZH-21 suppresses proliferation and migration of various colorectal cancer cells and induces apoptosis (apoptosis). It is applicable in cancer research, including studies on colorectal cancer.

ZWZH-21

ZWZH-21

😃Good
Catalog No. T212544Cas No. 3069195-42-9
WZH-21 is a selective and orally active dual HDAC1/2 inhibitor, exhibiting an IC50 of 34 nM for HDAC1 and 41 nM for HDAC2. It inhibits the growth of HCT116 and SW480 cells with IC50 values of 0.524 μM and 1.063 μM, respectively. WZH-21 suppresses proliferation and migration of various colorectal cancer cells and induces apoptosis (apoptosis). It is applicable in cancer research, including studies on colorectal cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
WZH-21 is a selective and orally active dual HDAC1/2 inhibitor, exhibiting an IC50 of 34 nM for HDAC1 and 41 nM for HDAC2. It inhibits the growth of HCT116 and SW480 cells with IC50 values of 0.524 μM and 1.063 μM, respectively. WZH-21 suppresses proliferation and migration of various colorectal cancer cells and induces apoptosis (apoptosis). It is applicable in cancer research, including studies on colorectal cancer.
Targets&IC50
HDAC1:34 nM
In vitro
ZWZH-21 effectively inhibits the growth of A549, MCF-7, and HepG2 cells, with IC 50 values of 1.66 μM, 2.445 μM, and 1.551 μM respectively. It suppresses the temperature-induced degradation of HDAC1/2 in HCT116 cells at concentrations of 0.4-1.6 μM over 48 hours. This compound also induces the degradation of HDAC1 and HDAC2 proteins and the formation of Ac-H3 and histone H4 in a concentration-dependent manner within HCT116 cells. ZWZH-21 reduces the colony-forming ability of HCT116 and SW480 cells and inhibits their migration while inducing apoptosis when applied at 0.4-2 μM for 48 hours. Additionally, ZWZH-21 triggers G1 phase arrest in HCT116 and SW480 cells under similar conditions.
In vivo
ZWZH-21 (2000 mg/kg, single oral dose) has demonstrated good safety in mice. In addition, ZWZH-21 (30-120 mg/kg, via gavage, administered daily for 14 days) effectively inhibited tumor growth in mice implanted with HCT116 human colon cancer xenografts.
Chemical Properties
Molecular Weight422.48
FormulaC26H22N4O2
Cas No.3069195-42-9
SmilesO=C(NC=1C=CC=CC1N)C2=CC=C(OCCN3C=4C=NC=CC4C=5C=CC=CC53)C=C2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy ZWZH-21 | purchase ZWZH-21 | ZWZH-21 cost | order ZWZH-21 | ZWZH-21 chemical structure | ZWZH-21 in vivo | ZWZH-21 in vitro | ZWZH-21 formula | ZWZH-21 molecular weight